# Effects of Huperzine A in Treatment of Moderate to Severe TBI

> **NCT01676311** · PHASE2 · TERMINATED · sponsor: **Spaulding Rehabilitation Hospital** · enrollment: 14 (actual)

## Conditions studied

- Traumatic Brain Injury

## Interventions

- **DRUG:** Huperzine A
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01676311
- **Lead sponsor:** Spaulding Rehabilitation Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-12
- **Primary completion:** 2018-08
- **Final completion:** 2018-08
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** Insufficient accrual rate: 14 participants enrolled (target of 30).
- **Last updated:** 2019-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01676311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01676311, "Effects of Huperzine A in Treatment of Moderate to Severe TBI". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01676311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*